The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Comparison of Risk Factors for the Competing Risks of Coronary Heart Disease, Stroke, and Venous Thromboembolism
Open accessAbstract
Methods for formal comparison of competing risks may clarify uncertainties about the associations of atherosclerotic risk factors with the development of venous thromboembolism (VTE). For a median of 20.1 years, the Physicians' Health Study (1982-2003) followed 18,662 US male physicians with no prior myocardial infarction, stroke, VTE, or cancer and for whom reported risk factor information was available at baseline. The authors used methods of competing risk survival analysis to compare relative hazard rates associated with age, hypertension, elevated cholesterol, diabetes, cigarette smoking, alcohol consumption, exercise frequency, body mass index, and height. During follow-up, coronary heart disease (CHD) occurred first in 1,348 men, stroke in 902 men, and VTE in 358 men. Incidence of all three outcomes increased with age, but the rate of increase was strongest for stroke. Hypertension, elevated cholesterol, diabetes, and smoking were associated with increased rates of CHD and stroke, with comparable magnitudes, but had no association with VTE. Conversely, higher body mass index was more strongly associated with risk of VTE than of either CHD or stroke, and taller men had a significantly increased risk of VTE but a lower risk of CHD. CHD and stroke have broadly comparable risk factor profiles that differ widely from the profile for VTE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341801 · Cited by 2,397
Self-citationFinal Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,264
Probability of stroke: a risk profile from the Framingham Study.
Wolf, P. A., D'Agostino, R. B., Belanger, A. J., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.3.312 · Cited by 1,782 · cited 2×
“Studies of cardiovascular risk in other populations indicate that hypertension has a generally stronger association with risk of stroke versus CHD whereas cholesterol has a generally stronger influence on risk of CHD (1, 2).”
BackgroundA general cardiovascular risk profile: The Framingham study
Kannel, W. B., McGee, D., & Gordon, T. (1976) · The American Journal of Cardiology · doi:10.1016/0002-9149(76)90061-8 · Cited by 1,189
Time-to-Event Analysis of Longitudinal Follow-up of a Survey: Choice of the Time-scale
Korn, E. L., Graubard, B. I., & Midthune, D. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009034 · Cited by 1,007
Applying Cox Regression to Competing Risks
Lunn, M., & McNeil, D. (1995) · Biometrics · doi:10.2307/2532940 · Cited by 975
Grady, D., Wenger, N. K., Herrington, D., Khan, S., Furberg, C., Hunninghake, D., Vittinghoff, E., Hulley, S., & for the Heart and Estrogen/progestin Replacement Study Research Group (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00002 · Cited by 715
Tsai, A. W., Cushman, M., Rosamond, W. D., Heckbert, S. R., Polak, J. F., & Folsom, A. R. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1182 · Cited by 700
Lee, E. W., Wei, L. J., Amato, D. A., & Leurgans, S. (1992) · Survival Analysis: State of the Art · doi:10.1007/978-94-015-7983-4_14 · Cited by 688
An Association between Atherosclerosis and Venous Thrombosis
Prandoni, P., Bilora, F., Marchiori, A., Bernardi, E., Petrobelli, F., Lensing, A. W. A., Prins, M. H., & Girolami, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022157 · Cited by 652
Pepe, M. S., & Mori, M. (1993) · Statistics in Medicine · doi:10.1002/sim.4780120803 · Cited by 620
A Prospective Study of Risk Factors for Pulmonary Embolism in Women
Goldhaber, S. Z. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540320044033 · Cited by 603
Chi-squared goodness-of-fit tests for the proportional hazards regression model
SCHOENFELD, D. (1980) · Biometrika · doi:10.1093/biomet/67.1.145 · Cited by 489
Hansson, P.-O., Eriksson, H., Welin, L., Svärdsudd, K., & Wilhelmsen, L. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.16.1886 · Cited by 310
Stokes, J., Kannel, W. B., Wolf, P. A., Cupples, L. A., & D’Agostino, R. B. (1987) · PubMed · Cited by 306
Survival Analysis: State of the Art.
Powell, S. J., Klein, J. P., & Goel, P. K. (1994) · The Statistician · doi:10.2307/2348153 · Cited by 208
Height and incidence of cardiovascular disease in male physicians.
Hebert, P. R., Rich-Edwards, J. W., Manson, J. E., Ridker, P. M., Cook, N. R., O'Connor, G. T., Buring, J. E., & Hennekens, C. H. (1993) · Circulation · doi:10.1161/01.cir.88.4.1437 · Cited by 202
Concept and usefulness of cardiovascular risk profiles
Kannel, W. B., D’Agostino, R. B., SULLIVAN, L. M., & Wilson, P. W. F. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.10.022 · Cited by 172
Glynn, R. J., L'Italien, G. J., Sesso, H. D., Jackson, E. A., & Buring, J. E. (2002) · Hypertension · doi:10.1161/hy1201.097199 · Cited by 140
Self-citationValidity of physicians' self-reports of cardiovascular disease risk factors
Klag, M. J., He, J., Mead, L. A., Ford, D. E., Pearson, T. A., & Levine, D. M. (1993) · Annals of Epidemiology · doi:10.1016/1047-2797(93)90074-e · Cited by 95
Methods to evaluate risks for composite end points and their individual components
Glynn, R. J., & ROSNER, B. A. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.02.001 · Cited by 70
Self-citation
Cited by
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Ridker, P. M., Everett, B. M., Pradhan, A., MacFadyen, J. G., Solomon, D. H., Zaharris, E., Mam, V., Hasan, A., Rosenberg, Y., Iturriaga, E., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1809798 · Cited by 1,317
Self-citationCardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis
Ageno, W., Becattini, C., Brighton, T., Selby, R., & Kamphuisen, P. W. (2008) · Circulation · doi:10.1161/circulationaha.107.709204 · Cited by 974
Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2
Chan, A. T., Ogino, S., & Fuchs, C. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067208 · Cited by 781
A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
Glynn, R. J., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900241 · Cited by 752
Self-citationEpidemiology and prevention of venous thromboembolism
Lutsey, P. L., & Zakai, N. A. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00787-6 · Cited by 507
Metadata
- Authors
- Glynn, R. J., & Rosner, B.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-10-05
- Volume
- 162
- Issue
- 10
- Pages
- 975-982
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2123269713
- Cited by
- 380
- References
- 25
- FWCI
- 10.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.